Surgical Unit of Abdominall Wall, Department of Digestive Surgery, "La Fe" Hospital, University of Valencia, 46008, Valencia, Spain.
Surg Endosc. 2019 Sep;33(9):2934-2940. doi: 10.1007/s00464-018-6597-y. Epub 2018 Nov 19.
Rives-Stoppa retromuscular repair (RSR) has been traditionally used to provide adequate coverage for large abdominal wall defects and appears to be more advantageous compared to other surgical techniques concerning complications and recurrence rates. The aim of this study was to identify the independent predictors associated to hernia recurrence after RSR in the treatment of incisional hernias.
This is a retrospective observational study of 213 patients who underwent RSR between June 2007 and January 2014 at a tertiary centre. Main inclusion criteria were adults with midline hernia classified as M1, M2, M3, M4, or M5, according to EHS classification. All the cases presented a transverse hernia defect measurement greater than 5 cm (grades W2 and W3). Recurrence rate was determined by clinical examination plus confirmation by abdominal CT scan.
At a median of 57.6 months (range 46-75 months) of postoperative follow-up, we reported 15 cases of recurrence (7.1%). Recurrences occurred after a mean period of 19.4 months (range 2-49 months). On multivariate analysis, steroid or immunosuppressive drugs use (OR 2.02; CI 1.16-3.95, p = 0.004), the development of postoperative hematoma (OR 2.9; CI 1.55-4.10, p = 0.001), and needing surgery for the hematoma (OR 2.1; CI 1.21-3.29, p = 0.004) were predictors of recurrence after RSR. There was no significant difference in recurrence rate among obesity, smoking, urgent repair, type of mesh fixation, operative time, type of prosthesis, or concomitant procedures.
In our current study, using immunosuppressive drugs, the development of postoperative hematoma and needing surgery for the hematoma were associated with increased risk of hernia recurrence after RSR.
Rives-Stoppa 肌后修补术(RSR)传统上用于为大的腹壁缺损提供充分的覆盖,并且在并发症和复发率方面似乎比其他手术技术更具优势。本研究的目的是确定 RSR 治疗切口疝后与疝复发相关的独立预测因素。
这是一项回顾性观察研究,纳入了 2007 年 6 月至 2014 年 1 月在一家三级中心接受 RSR 的 213 例患者。主要纳入标准为根据 EHS 分类为 M1、M2、M3、M4 或 M5 的中线疝的成年患者。所有病例均存在横疝缺损测量值大于 5cm(W2 和 W3 级)。复发率通过临床检查加腹部 CT 扫描确认来确定。
在术后随访中位数为 57.6 个月(范围 46-75 个月)时,我们报告了 15 例复发(7.1%)。复发发生在平均 19.4 个月(范围 2-49 个月)后。多变量分析显示,使用类固醇或免疫抑制剂(OR 2.02;95%CI 1.16-3.95,p=0.004)、术后血肿形成(OR 2.9;95%CI 1.55-4.10,p=0.001)和需要手术治疗血肿(OR 2.1;95%CI 1.21-3.29,p=0.004)是 RSR 后复发的预测因素。肥胖、吸烟、急诊修复、网片固定类型、手术时间、假体类型或同时进行的手术在复发率方面没有显著差异。
在我们的研究中,使用免疫抑制剂、术后血肿形成和需要手术治疗血肿与 RSR 后疝复发的风险增加相关。